The aim of this randomized controlled trial is to investigate the effects of different aerobic modalities; moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT), and a nutritional intervention (D) on appetite regulation, appetite-related hormones, neural responses to food cues (EEG), and exosome-derived molecular signals in patients with type 2 diabetes (T2D) and obesity. It will also examine whether these effects differ between men and women. The main questions it aims to answer are: * What is the isolated and combined effect of these exercise modalities and diet on glucose metabolism, insulin dynamics, miRNA exosomal expression, appetite hormones, and neural responses to food stimuli? * Is there a sex-specific best combination choice for improving appetite regulation and metabolic control? * Are changes in miRNA exosomal profile, appetite-related hormones, and EEG-based neural responses associated with other health-related outcomes such as body composition, fat mass reduction, insulin sensitivity, physical condition, and quality of life? To answer these questions, researchers designed a two-factor study. One factor was diet, with two levels Diet (D) and no diet (ND). The second factor was exercise, with three levels (inactive (INACT), MICT, and HIIT). Participants were randomly allocated into six groups: ND-INACT, ND-MICT, ND-HIIT, D-INACT, D-MICT, and D-HIIT. Participants will: * Undergo a 12-week intervention within their assigned group. * Visit the research facilities three times per week if assigned to an exercise group, or once every two weeks if in a diet group.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Assessed changes in Glucose concentration
Timeframe: Pre and Post the 12-week intervention
Assessed changes in Insulin concentration
Timeframe: Pre and Post the 12-week intervention
Assessed changes in Insulin Resistance: HOMA-IR
Timeframe: Pre and Post 12-week intervention
Assessed changes in Insulin Sensitivity: Matsuda Index
Timeframe: Pre and Post 12-week intervention
Assessed changes in Insulin Sensitivity: Quicki
Timeframe: Pre and Post 12-week intervention
Assessed changes in Plasma Exosomal miRNA expression
Timeframe: Pre and Post the 12-week intervention
Assessed changes in Appetite hormones
Timeframe: Pre and Post the 12-week intervention
Assessed changes in task of emotional reactivity to food images
Timeframe: Pre and Post the 12-week intervention
Assessed changes in Appetite assessment.
Timeframe: Pre and Post the 12-week intervention
Assessed changes in Body Weight
Timeframe: Pre and Post the 12-week intervention
Assessed in Height
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Body Mass Index
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Fat Mass (kilograms of Fat Mass)
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Fat Mass (percentage of Fat Mass)
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Fat-free Mass (kilograms of Fat-free Mass)
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Fat-free Mass (percentage of Fat-free Mass)
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Anthropometry: Perimeters
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Anthropometry: Waist to Hip Ratio
Timeframe: Pre and Post 12-week Intervention
Assessed changes in Anthropometry: Skinfold thickness
Timeframe: Pre and Post 12-week Intervention